跳至主要内容
临床试验/NCT06301061
NCT06301061尚未招募不适用

Effectiveness of Focal Microvibration in the Management of Chronic Lumbosacral Radicular Pain: a Randomized Controlled Study

Federico II University0 个研究点目标入组 150 人开始时间: 2024年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
150
主要终点
Pain intensity

研究概览

简要总结

The goal of this clinical trial is to investigate the effectiveness of focal microvibration on patients affected by chronic lumbosacral radicular pain. The main question[s] it aims to answer are:

  • Can focal microvibration improve pain in this patient population?
  • Can focal microvibration improve quality of life in these patients? Participants will attach to their skin four little devices (10x20x0,5mm) delivering focal microvibration in the painful area according to researchers indications for 6 hours/day every day except Thursday and Sunday.

Researchers will compare patients treated with focal microvibration to patients treated with a sham device and to patients treated with standard pharmacological therapy.

详细描述

This is the first randomized controlled study aiming to assess the potential use of focal microvibration for the management of chronic lumbosacral radicular pain which is the pain consequent to the compression of a spinal nerve root. Focal microvibration has been so far used to treat gait disorders and instability consequent to diseases such as Parkinson's disease, stroke, ataxia, multiple sclerosis with impressive results and no reported side effects. Our trial involves three arms: one arm treated with a device able to deliver focal microvibration, one arm treated with a sham device, and one arm treated with standard pharmacological therapy according to international guidelines. Patients with the active and with sham devices will attach them on their skin for 6 hours/day except on Thursday and Sunday: this application schedule with two days of treatment suspension has intended to avoid habituation to the sub-perception microvibration stimulation. The follow up will be 12 months and periodic visits will be performed after 7, 15 30, 45, 60, 90, 180, and 360 days of treatment. All the patients enrolled in the study will have access to rescue analgesic drugs such as paracetamol 1g and tramadol 100mg in case on excessive pain. Randomization will be performed by a computer-generated sequence. During the follow up visits, patients will be asked to fill questionnaires to explore and monitor pain intensity and pain interference in daily life: brief pain inventory (BPI) and Oswestry disability index (ODI)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pain duration≥6 months
  • Magnetic resonance imaging (MRI) showing compression of lumbosacral nerve roots
  • Neuropathic symptoms in the innervation territory of the compressed spinal nerve roots
  • Monolateral pain
  • Pain intensity: moderate-severe i.e. numeric rating scale (NRS)≥4.

排除标准

  • Psychiatric patients
  • Cancer patients
  • Patients affected by disease characterized by spasticity or muscular stiffness:
  • Parkinson's disease, multiple sclerosis, stroke, spine injuries.
  • Patients with spinal or dorsal root ganglion stimulators
  • Patients undergone central of peripheral stimulation in the past 3 months
  • Patients affected by fibromyalgia.
  • Patients undergone central nervous system surgery
  • Patients with reduced renal function eGFR≤60ml/min/1,73m2

研究组 & 干预措施

Patients treated with Focal Microvibration

Experimental

Patients will be treated with focal microvibration through the application on the skin of four devices for 6 hours/day every day except thursady and Sunday.

干预措施: Equistasi® (Device)

Patients treated with a Sham device

Sham Comparator

Patients will be treated with four sham device which will be attached on the skin for 6 hours/day every day except thursady and Sunday.

干预措施: Sham (Device)

Patients treated with standard pharmacological approach

Active Comparator

Patients will be treated with standard pharmacological therapy

干预措施: Gabapentin; Pregabalin; Duloxetine; Amitriptyline (Drug)

结局指标

主要结局

Pain intensity

时间窗: 12 months

Change in pain intensity with numeric rating scale (NRS): NRS ranges from 0 (no pain) to 10 (the the worst pain imaginable)

次要结局

  • Pain interference in daily life(12 months)
  • Disability(12 months)

研究者

发起方
Federico II University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Vargas

Prof

Federico II University

相似试验